Ken Griffin Longboard Pharmaceuticals, Inc. Call Options Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$27.58 - $39.5 $104,804 - $150,100
3,800 Added 44.71%
12,300 $409,000
Q2 2024

Aug 14, 2024
BUY
$17.0 - $27.03 $103,700 - $164,883
6,100 Added 254.17%
8,500 $229,000
Q1 2024

May 15, 2024
BUY
$18.89 - $26.06 $45,336 - $62,544
2,400 New
2,400 $51,000

Others Institutions Holding LBPH

# of Institutions
126
Shares Held
34.9M
Call Options Held
28.9K
Put Options Held
13.9K
View Full List

About Longboard Pharmaceuticals, Inc.

LBPH Quotes by TradingView
  • Ticker LBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,586,000
  • Market Cap $815M
  • Description
  • Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...
More about LBPH
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email